Press releases
Read more:
Categories
2022
2022-02-08 08:56
Nanologica's Year-End Report 2021
FINANCIAL SUMMARY SIGNIFICANT EVENTS IN THE FOURTH QUARTER AN EXCITING TIME AHEAD During the year, major changes have been made in the company's two...
2022-01-19 09:48
Nanologica Changes Dates for Financial Reports
Nanologica's Year-end report for 2021 will be published on Tuesday February 8, instead of January 31 as previously announced, and the company's...
2022-01-19 09:44
Nanologica Signs Credit Line with Main Owner
Nanologica AB has signed a credit line of up to MSEK 50 with the company's main owner Flerie Invest AB. The aim is to cover the company's temporary...
2021
2021-12-20 08:15
Stock option program in Nanologica ab fully subscribed
The option program 2021/24 for Nanologica AB resolved by the Annual General Meeting 2021 has now been implemented. The program was subscribed at 100 percent...
2021-12-06 10:13
Nanologica Recruits VP Chromatography
Nanologica has recruited Katarina Alenäs as VP Chromatography to lead Nanologica's sales organization within Chromatography globally. As sales...
In accordance with the decision taken at the annual general meeting on May 27, 2021, the three largest shareholders as of September 30, 2021 have been...
2021-09-17 11:15
Nanologica Closes NIC-001
Nanologica AB has decided to close the project with the drug candidate NIC-001 for the treatment of gastroparesis before the planned clinical study begins...
2021-08-19 08:20
Nanologica Recruits Chief Scientific Officer
Nanologica has recruited Gary Pitcairn as Chief Scientific Officer as part of the strategy to increase the focus on inhalation and respiratory diseases...
Nanologica has completed the first study within the tox program for the inhalation platform NLAB Spiro®. The program now continues with further studies...
2021-06-30 19:55
Exercise of Rights in Nanologica’s Stock Option Program
In Nanologica's stock option program 2018/21 exercise of rights in Nanologica’s stock option program has increased the number of shares in the...